Idaman Pharma

Name

Idaman Pharma

Legal name

Idaman Pharma Sdn. Bhd.

Website

https://idamanpharma.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

akta.pro secondary industry

OTC, Vitamins & Supplement Management (HSABALAM)

Keywords

• Pharmaceutical distribution
• Medical device supply
• Antivenom manufacturing
• Pharmaceutical products
• Healthcare equipment

Headquarters

HQ city

Kuala Lumpur

HQ country

Malaysia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Idaman Pharma generates revenue through the distribution and sale of pharmaceutical products, medical devices, and healthcare equipment directly to licensed manufacturers and healthcare providers. The company supplies products including antivenins, cardiovascular drugs, surgical supplies, and consumer healthcare items.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Idaman Pharma is a licensed pharmaceutical and medical device supplier based in Kuala Lumpur, Malaysia. The company distributes and supplies a portfolio of registered pharmaceutical products—including antivenoms (Cobra and Malayan Pit Viper), thrombolytics, cardiovascular drugs, opioid analgesics, neuromuscular blocking agents, ophthalmic solutions, and vitamins—along with medical devices and healthcare equipment directly sourced from licensed manufacturers to healthcare institutions.

Product overview

Idaman Pharma is a pharmaceutical and medical device supplier offering a portfolio of registered pharmaceutical products and healthcare equipment. The product portfolio includes therapeutic medications (injectable solutions, tablets, capsules, suppositories, and eye drops), antivenom products (Cobra Antivenin and Malayan Pit Viper Antivenin), vitamins (Vitamin C formulations), and cosmetics (hand sanitizers in multiple scents). The company positions itself as a licensed pharmaceutical supplier offering high-quality products at affordable prices, with services including product inventory supply and customer support.

Differentiator

Problem solved

Functional benefit

Brands

• Streptokinase Karma: Streptokinase 1,500,000 IU Powder for Solution for Infusion
• Doproct
• Decostriol
• Enahexal
• Felocor
• Idaman Hand Sanitizer
• Vit C

Products and services

• Cobra Antivenin

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Regional players

• BioCare Group (BioCare Pharmaceutical): Malaysia-based pharmaceutical company operating in distribution and specialty therapeutic segments including antivenoms and critical care products. Directly comparable niche product focus and Malaysian institutional customer base.
• Apex Pharmacy Marketing Sdn Bhd: Malaysian pharmaceutical wholesaler and distributor serving independent pharmacies and healthcare providers. Comparable business model as a mid-sized Malaysian pharmaceutical distributor serving healthcare channel customers.

Broad incumbents

• CCM Pharmaceuticals (Chemical Company of Malaysia): Malaysian pharmaceutical manufacturer and distributor with diversified prescription and consumer health brands. Competes with Idaman Pharma across both institutional supply and consumer healthcare categories.
• Pharmaniaga Berhad: Malaysia's largest listed pharmaceutical distributor and manufacturer, supplying hospitals, clinics, and government institutions nationwide. Direct competitor in pharmaceutical distribution and a far larger incumbent against whom Idaman Pharma bids on institutional tenders.

Direct peers

• Duopharma Biotech Berhad: Malaysian pharmaceutical manufacturer and distributor with a registered product portfolio of prescription and OTC medicines. Comparable in regulatory positioning (NPRA-registered) and target market (Malaysian healthcare institutions), though operating at significantly larger scale.
• Hovid Berhad: Malaysian pharmaceutical manufacturer producing generic and branded finished dosage forms distributed domestically and regionally. Comparable product mix and Malaysian healthcare institutional customer base.
• Y.S.P. Industries (Yung Shin Pharmaceutical): Malaysian pharmaceutical manufacturer with a wide prescription generic portfolio distributed to hospitals and clinics. Comparable in product mix, NPRA-registered positioning, and channel focus.
• Kotra Pharma (Kotra Industries Berhad): Malaysian pharmaceutical manufacturer and distributor with a broad portfolio of prescription generics and OTC products supplied to hospitals and pharmacies. Overlaps directly with Idaman Pharma's product categories and channel focus.

Market position

Strengths4 records

Weaknesses2 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/idaman-pharma-manufacturing-sdn-bhd-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Idaman Pharma